Determination of the site of metabolism of total, free, and complexed prostate-specific antigen

被引:34
作者
Kilic, S
Yalcinkaya, S
Guntekin, E
Kukul, E
Deger, N
Sevuk, M
机构
[1] Akdeniz Univ, Tip Fak, Sch Med, Dept Urol, TR-07070 Antalya, Turkey
[2] Univ Akdeniz, Sch Med, Dept Cardiol, Antalya, Turkey
关键词
D O I
10.1016/S0090-4295(98)00208-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine the site of metabolism of total prostate-specific antigen (tPSA), free PSA (fPSA), and complexed PSA (cPSA). Methods. A total of 20 male patients, 50 years old or older, having a clinical indication for left and right heart catheterization were enrolled in this study. Selective blood samples were obtained from the infrarenal, infrahepatic, and suprahepatic inferior vena cava, renal vein, hepatic vein, superior vena cava, pulmonary artery, and femoral artery. cPSA concentration was accepted as the difference between tPSA and fPSA concentrations. Results. We found that tPSA and fPSA concentrations in the infrarenal inferior vena cava were significantly higher than in the systemic artery. There was no significant difference between the systemic artery and the infrarenal inferior vena cava for cPSA concentration. Although fPSA concentration decreased significantly across the renal circulation, the decreases in cPSA and tPSA concentrations were statistically insignificant. In the hepatic circulation, we found that tPSA, fPSA, and cPSA concentrations were significantly decreased. No decrease in tPSA, fPSA, and cPSA concentrations were noted across the pulmonary circulation. Conclusions. Our results indicate that fPSA and tPSA are released into serum from the prostate but the prostate may not have a significant role in complex formation of PSA. In addition, the liver has a significant role in the elimination of tPSA, fPSA, and cPSA. By contrast, the kidneys have a significant role only in the elimination of fPSA. We also found that the lungs did not have a significant role in the elimination of tPSA, fPSA, or cPSA. UROLOGY 52: 470-473, 1998. (C) 1998, Elsevier Science Inc. All rights reserved.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 13 条
[1]   Prostate specific antigen is metabolized in the liver [J].
Agha, AH ;
Schechter, E ;
Roy, JB ;
Culkin, DJ .
JOURNAL OF UROLOGY, 1996, 155 (04) :1332-1335
[2]   ENZYMATIC-ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS REACTIONS WITH EXTRACELLULAR SERINE PROTEINASE-INHIBITORS [J].
CHRISTENSSON, A ;
LAURELL, CB ;
LILJA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (03) :755-763
[3]   PROSTATE-SPECIFIC ANTIGEN IS NOT EXCRETED BY HUMAN KIDNEY OR ELIMINATED BY ROUTINE HEMODIALYSIS [J].
KABALIN, JN ;
HORNBERGER, JC .
UROLOGY, 1991, 37 (04) :308-310
[4]  
LILJA H, 1991, CLIN CHEM, V37, P1618
[5]  
LILJA H, 1993, UROL CLIN N AM, V20, P681
[6]   PROSTATE SPECIFIC ANTIGEN IN THE PREOPERATIVE AND POSTOPERATIVE EVALUATION OF LOCALIZED PROSTATIC-CANCER TREATED WITH RADICAL PROSTATECTOMY [J].
OESTERLING, JE ;
CHAN, DW ;
EPSTEIN, JI ;
KIMBALL, AW ;
BRUZEK, DJ ;
ROCK, RC ;
BRENDLER, CB ;
WALSH, PC .
JOURNAL OF UROLOGY, 1988, 139 (04) :766-772
[7]  
Partin AW, 1996, PROSTATE, P35
[8]   INVIVO CATABOLISM OF ALPHA-1-ANTICHYMOTRYPSIN IS MEDIATED BY THE SERPIN RECEPTOR WHICH BINDS ALPHA-1-PROTEINASE INHIBITOR, ANTITHROMBIN-III AND HEPARIN COFACTOR-II [J].
PIZZO, SV ;
MAST, AE ;
FELDMAN, SR ;
SALVESEN, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 967 (02) :158-162
[9]   PROSTATE-SPECIFIC ANTIGEN AS A SERUM MARKER FOR ADENOCARCINOMA OF THE PROSTATE [J].
STAMEY, TA ;
YANG, N ;
HAY, AR ;
MCNEAL, JE ;
FREIHA, FS ;
REDWINE, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) :909-916
[10]  
STENMAN UH, 1991, CANCER RES, V51, P222